Identification of Candida albicans and Candida glabrata within 1.5 hours directly from positive blood culture bottles with a shortened peptide nucleic acid fluorescence in situ hybridization protocol

Journal of Clinical Microbiology

Volumn 47, Issue 1, 2009, Pages 247-248

  Gherna, Michael ^a   Merz, William G ^a,b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDE NUCLEIC ACID;

ARTICLE; BLOOD CULTURE; CANDIDA ALBICANS; CANDIDA GLABRATA; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; NONHUMAN; PRIORITY JOURNAL;

BLOOD; CANDIDA ALBICANS; CANDIDA GLABRATA; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MYCOLOGY; PEPTIDE NUCLEIC ACIDS; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

CANDIDA ALBICANS; CANDIDA GLABRATA;

EID: 58849109522     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01241-08     Document Type: Article

References (10)

1. Büchner, T., W. Fegeler, H. Bernhardt, N. Brockmeyer, K.-H. Duswald, M. Herrmann, D. Heuser, U. Jehn, G. Just-Nübling, M. Karthaus, G. Maschm-eyer, F.-M. Müller, J. Ritter, N. Roos, M. Ruhnke, A. Schmalreck, R. Schwarze, G. Schwesinger, and G. Silling. 2002. Treatment of severe Candida infections in high-risk patients in Germany: consensus formed by a panel of interdisciplinary investigators. Eur. J. Clin. Microbiol. Infect. Dis. 21:337-352.
2. Davis, L. E., C. E. Shields, and W. G. Merz. 2005. Use of a commercial reagent leads to reduced germ tube production by Candida dubliniensis. J. Clin. Microbiol. 43:2465-2466.
3. Dealler, S. F. 1991. Candida albicans colony identification in 5 minutes in a general microbiology laboratory. J. Clin. Microbiol. 29:1081-1082.
4. Freydiere, A. M., R. Guinet, and P. Boiron. 2001. Yeast identification in the clinical microbiology laboratory: phenotypic methods. Med. Mycol. 39:9-33.
5. Hazen, K. C., and S. A. Howell. 2007. Candida, Cryptococcus, and other yeasts of medical importance, p. 1762-1788. In P. R. Murray, E. J. Baron, J. H. Jorgensen, M. L. Landry, and M. A. Pfaller (ed.), Manual of clinical microbiology, 9th ed., vol. 2. ASM Press, Washington, DC.
6. Odds, F. C., and R. Bernaerts. 1994. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J. Clin. Microbiol. 32:1923-1929.
7. Pfaller, M. A., A. Houston, and S. Coffman. 1996. Application of CHROMagar Candida for rapid screening of clinical specimens for Candida albicans, Candida tropcalis, Candida krusei, and Candida (Torulopsis) glabrata. J. Clin. Microbiol. 34:58-61.
8. Pfaller, M. A., D. J. Diekema, M. G. Rinaldi, R. Barnes, B. Hu, A. V. Veselov, N. Tiraboschi, E. Nagy, and D. L. Gibbs. 2005. Results from the ARTEMIS DISK Global Antifungal Surveillance Study: a 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing. J. Clin. Microbiol. 43:5848-5859.
9. Piens, M. A., J. D. Perry, H. Raberin, F. Parant, and A. M. Freydiere. 2003. Routine use of a one minute trehalase and maltase test for the identification of Candida glabrata in four laboratories. J. Clin. Pathol. 56:687-689.
10. Shepard, J. R., R. M. Addison, B. D. Alexander, P. Della-Latta, M. Gherna, G. Hasse, G. Hall, J. K. Johnson, W. G. Merz, H. Peltroche-Llacsahuanga, H. Stender, R. A. Venezia, D. Wilson, G. W. Procop, F. Wu, and M. J. Fiandaca. 2008. Multicenter evaluation of the Candida albicans/Candida glabrata peptide nucleic acid fluorescent in situ hybridization method for simultaneous dual-color identification of Candida albicans and Candida glabrata directly from blood culture bottles. J. Clin. Microbiol. 46:50-55.